GestVision is a leading brand in the United States that specializes in providing solutions for the diagnosis and management of preeclampsia, a serious disease that affects pregnancy. Preeclampsia is characterized by high blood pressure and can have detrimental effects on the health of both mother and child. Currently, there are no FDA-approved diagnostic tests for preeclampsia in the US, making it challenging for doctors to accurately diagnose the condition.

However, GestVision aims to revolutionize prenatal care by offering a groundbreaking diagnostic test called the GestAssured Test. This test can help doctors rule out preeclampsia in many patients, enabling them to make more informed decisions about the need for further care or early delivery. Preeclampsia is a significant concern globally, affecting 5-8% of pregnancies worldwide.

It is responsible for a staggering number of maternal deaths and the loss of thousands of babies each year. With its focus on innovation and improving the lives of pregnant women, GestVision is at the forefront of advancing prenatal care and ensuring the well-being of both mothers and their children. For more information about preeclampsia and GestVision's groundbreaking solutions, visit their website or contact their corporate offices located in Groton, CT